Lexicon Pharmaceuticals (LXRX) Shares Repurchased (2011 - 2024)
Lexicon Pharmaceuticals (LXRX) reported Shares Repurchased of $1.7 million for Q1 2024, up 109.95% year-over-year from $824000.0 in Q2 2023, and up 109.95% on a QoQ basis from $824000.0 in Q1 2023.
Lexicon Pharmaceuticals (LXRX) has 14 years of Shares Repurchased data on file, last reported at $1.7 million in Q1 2024.
- Quarterly Shares Repurchased rose 109.95% year-over-year to $1.7 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $1.7 million (up 109.95% YoY) and the FY2024 annual result came in at $1.7 million, up 109.95% from the prior year.
- Shares Repurchased improved to $1.7 million in Q1 2024 per LXRX's latest filing, from $824000.0 in the prior quarter.
- Across five years, Shares Repurchased topped out at $2.7 million in Q3 2021 and bottomed at -$1.0 million in Q4 2020.
- The 5-year median for Shares Repurchased is $864000.0 (2022), against an average of $870428.6.
- The widest annual swing landed in 2020, when Shares Repurchased retreated 9.03%; it then surged 109.95% in 2024.
- Tracing LXRX's Shares Repurchased over 5 years: stood at -$1.0 million in 2020, then soared by 360.72% to $2.7 million in 2021, then slumped by 67.7% to $864000.0 in 2022, then retreated by 4.63% to $824000.0 in 2023, then jumped by 109.95% to $1.7 million in 2024.
- Per Business Quant, the three latest LXRX Shares Repurchased figures stand at $1.7 million (Q1 2024), $824000.0 (Q1 2023), and $864000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Lexicon Pharmaceuticals | 872.52 Mn | 701.87 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2023 | 824,000.00 |
| Mar 31, 2023 | 824,000.00 |
| Jun 30, 2022 | 864,000.00 |
| Jun 30, 2022 | 864,000.00 |
| Sep 30, 2021 | 2.68 Mn |
| Sep 30, 2021 | 2.68 Mn |
| Dec 31, 2020 | -1.03 Mn |
| Dec 31, 2020 | -1.03 Mn |
| Jun 30, 2020 | 103,000.00 |
| Jun 30, 2020 | 103,000.00 |
| Mar 31, 2020 | 923,000.00 |
| Mar 31, 2020 | 923,000.00 |
| Dec 31, 2019 | -941,000.00 |
| Dec 31, 2019 | -941,000.00 |
| Mar 31, 2019 | 941,000.00 |
| Mar 31, 2019 | 941,000.00 |
| Mar 31, 2018 | 972,000.00 |
| Mar 31, 2018 | 972,000.00 |
| Mar 31, 2017 | 1.68 Mn |
| Mar 31, 2017 | 1.68 Mn |
| Mar 31, 2016 | 621,000.00 |
| Mar 31, 2016 | 621,000.00 |
| Mar 31, 2015 | 357,000.00 |
| Mar 31, 2015 | 357,000.00 |
| Mar 31, 2014 | 887,000.00 |
| Mar 31, 2014 | 887,000.00 |
| Mar 31, 2013 | 873,000.00 |
| Mar 31, 2013 | 873,000.00 |
| Mar 31, 2012 | 285,000.00 |
| Mar 31, 2012 | 285,000.00 |
| Mar 31, 2011 | 108,000.00 |
| Mar 31, 2011 | 108,000.00 |